ALNA Allena Pharmaceuticals Inc

Price (delayed)

$0.9107

Market cap

$52.54M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.93

Enterprise value

$26.73M

Highlights
Allena Pharmaceuticals's equity has soared by 121% YoY and by 4.1% from the previous quarter
The EPS has soared by 51% year-on-year and by 8% since the previous quarter
ALNA's quick ratio has soared by 111% year-on-year but it is down by 6% since the previous quarter
ALNA's net income is up by 15% year-on-year but it is down by 12% since the previous quarter
Allena Pharmaceuticals's debt has increased by 11% YoY

Key stats

What are the main financial stats of ALNA
Market
Shares outstanding
57.69M
Market cap
$52.54M
Enterprise value
$26.73M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.2
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$36.41M
EBITDA
-$35.67M
Free cash flow
-$30.69M
Per share
EPS
-$0.93
Free cash flow per share
-$0.56
Book value per share
$0.41
Revenue per share
$0
TBVPS
$0.74
Balance sheet
Total assets
$40.47M
Total liabilities
$16.97M
Debt
$10.47M
Equity
$23.5M
Working capital
$31.76M
Liquidity
Debt to equity
0.45
Current ratio
5.71
Quick ratio
5.38
Net debt/EBITDA
0.72
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-105.1%
Return on equity
-178.6%
Return on invested capital
-513.7%
Return on capital employed
-108%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ALNA stock price

How has the Allena Pharmaceuticals stock price performed over time
Intraday
0.1%
1 week
-8.93%
1 month
-31.01%
1 year
-35.87%
YTD
-28.85%
QTD
-29.95%

Financial performance

How have Allena Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$35.87M
Net income
-$36.9M
Gross margin
N/A
Net margin
N/A
The operating income has grown by 18% YoY but it has contracted by 12% from the previous quarter
ALNA's net income is up by 15% year-on-year but it is down by 12% since the previous quarter

Growth

What is Allena Pharmaceuticals's growth rate over time

Valuation

What is Allena Pharmaceuticals stock price valuation
P/E
N/A
P/B
2.2
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has soared by 51% year-on-year and by 8% since the previous quarter
Allena Pharmaceuticals's equity has soared by 121% YoY and by 4.1% from the previous quarter
ALNA's price to book (P/B) is 19% lower than its last 4 quarters average of 2.7

Efficiency

How efficient is Allena Pharmaceuticals business performance
ALNA's ROIC is up by 41% YoY
Allena Pharmaceuticals's return on assets has increased by 7% YoY
The ROE has grown by 7% YoY and by 5% from the previous quarter

Dividends

What is ALNA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ALNA.

Financial health

How did Allena Pharmaceuticals financials performed over time
Allena Pharmaceuticals's total assets is 138% higher than its total liabilities
ALNA's quick ratio has soared by 111% year-on-year but it is down by 6% since the previous quarter
The current ratio has soared by 101% YoY but it has contracted by 6% from the previous quarter
Allena Pharmaceuticals's debt is 55% less than its equity
Allena Pharmaceuticals's equity has soared by 121% YoY and by 4.1% from the previous quarter
Allena Pharmaceuticals's debt to equity has decreased by 49% YoY and by 4.3% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.